Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03248856
Other study ID # 1456/2017
Secondary ID 2017-002377-19
Status Completed
Phase Phase 1
First received
Last updated
Start date October 2, 2017
Est. completion date May 31, 2021

Study information

Verified date September 2021
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study Triamcinolone acetonide will be applied intratympanically before cochlear implant surgery. After round window exposure, a perilymph sample and simultaneously a blood sample will be drawn. Triamcinolone levels will then be analyzed in the samples.


Description:

At the ENT department of the university hospital Vienna (AKH Wien) patients are treated with intratympanic triamcinolone acetonide before cochlea implantation to reduce inflammation and in some cases to protect residual hearing. Triamcinolone acetonide levels in cochlear perilymph will be evaluated in an open prospective clinical study. Patients scheduled for cochlear implant surgery between 18 and 90 years will be included. Patients who are treated with steroids preoperatively will be excluded from the study. Patients will be randomized after inclusion to one of four groups. The randomization is carried out to generate hypothesis for the needed dose and best time of application in the future. Triamcinolone acetonide will then be applied 20-24h before surgery or at the beginning of the surgery, depending on randomization (see below). About 20 µl of perilymph will be sampled simultaneously to a blood sample during cochlear implant surgery. The probes will be stored at -80°C. Triamcinolone acetonide levels of the blood and perilymph will be determined by the pharmaceutical laboratory (Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna). The patients will be randomized to 4 groups. Group 1 - Volon A 10mg administration 20 - 24 hours before sampling. Group 2 - Volon A 40mg administration 20 - 24 hours before sampling. Group 3 Volon A 10mg - administration 1 to 2 hours before sampling. Group 4 - Volon A 40mg administration 1 to 2 hours before sampling. The time interval of application (1 to 2 hours and 20 to 24 hours before sampling) are a result of varying time of surgery depending on surgeons and patient anatomy as well as day to day clinical organization. Patients can withdraw consent at any time of the study. The active phase of each patient will be between 6 and 9 days depending on time of follow-up visit.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 31, 2021
Est. primary completion date December 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Patients between 18 and 90 years will be included in the study, who will undergo a cochlear implantation and are willing to participate in the study Exclusion Criteria: - Patients younger than 18 years - Patients who receive cortisone on a regular basis or receive cortisone i.v. or p.o. preoperatively - Patients with contraindications against the administration of Volon A

Study Design


Intervention

Drug:
Triamcinolone Acetonide
Intratympanic administration

Locations

Country Name City State
Austria Medical University of Vienna (AKH) Vienna

Sponsors (1)

Lead Sponsor Collaborator
Christoph Arnoldner

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Triamcinolone levels in comparison Absorption of Triamcinolone acetonide in cochlear perilymph in comparison to dissemination to the blood circulation 2 years
Secondary Triamcinolone stability The stability of triamcinolone acetonide levels in the cochlear perilymph 2 years
Secondary Triamcinolone concentrations Perilymph concentrations and blood concentrations of triamcinolone acetonide after administration of different Triamcinolone acetonide doses. 2 years
Secondary Impedances Difference of impedances of patients receiving different doses at different timepoints 2 years
See also
  Status Clinical Trial Phase
Completed NCT03212924 - Listening Effort in Cochlear Implant Users N/A
Withdrawn NCT04041596 - Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook Phase 4
Recruiting NCT04610112 - PMCF on Safety and Performance of HiResTM Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss
Completed NCT04610216 - Investigation of the Automatic Technology on the Naída M Hearing Devices
Completed NCT03288753 - Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors N/A
Completed NCT04048239 - Development of a Robotic Minimally Invasive Pathway for Cochlear Implantation N/A
Completed NCT04815343 - Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios N/A
Completed NCT04145661 - Non-linear Frequency Compared to Conventional Processing in Patients With and Without Cochlear Dead Regions. N/A
Recruiting NCT06114680 - Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy N/A
Completed NCT03756337 - Neuro 1 vs. Neuro 2 Sound Processors N/A
Completed NCT04120181 - A New Predictor Marker for Cochlear Implants Infection
Terminated NCT05586555 - A Monocentric Study Evaluating Pupillometry as an Objective Measurement for CI Fittings N/A
Recruiting NCT04929470 - Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss
Completed NCT04183348 - Evaluation of the Effect of a Visio-Hearing Training Protocol on Spatial Hearing in Subjects With Hearing Loss N/A
Not yet recruiting NCT06420921 - MeasurIng and Restoring Auditory Awareness for Cochlear Implant Listeners in noisE N/A
Completed NCT06235073 - Robotic and Manual Cochlear Implantation: An Intra-individual Study of Speech Recognition and Electrode Holder Position (ICRobMan)
Recruiting NCT05486637 - Vocal Emotion Communication With Cochlear Implants Early Phase 1
Recruiting NCT06301568 - Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation
Recruiting NCT06301581 - Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant
Withdrawn NCT04651660 - Using Electrocochleography During Cochlear Implantation of the Neuro Zti. N/A